海普瑞：2021年報.pdf

1、ANNUAL REPORT 2021 年度報告(A joint stock company incorporated in the Peoples Republic of China with limited liability)Stock Code 股份代號:9989（於中華人民共和國註冊成立的股份有限公司）CONTENTS目 錄Corporate Information 2公司資料Financial Highlights 5財務摘要Chairmans Statement 6董事長致辭Management Discussion and Analysis 9管理層討論與分析Directors,

2、Supervisors and Senior Management 28董事、監事及高級管理層Directors Report 34董事會報告Corporate Governance Report 60企業管治報告Independent Auditors Report 80獨立核數師報告Consolidated Statement of Profit or Loss 91綜合損益表Consolidated Statement of Comprehensive Income 92綜合全面收益表Consolidated Statement of Financial Position 93綜合財務狀

3、況表Consolidated Statement of Changes in Equity 95綜合權益變動表Consolidated Statement of Cash Flows 97綜合現金流量表Notes to Financial Statements 101財務報表附註SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO.,LTD.深圳市海普瑞藥業集團股份有限公司 ANNUAL REPORT 2021 年度報告Corporate Information公司資料2Board of DirectorsExecutive DirectorsMr.Li Li(C

4、hairman)Ms.Li Tan(Deputy General Manager)Mr.Shan Yu(General Manager)Mr.Zhang Bin(appointed on May 26,2021)(resigned on April 29,2022)Mr.Sun Xuan(Vice Chairman)(resigned on May 6,2021)Non-executive DirectorMr.Bu Haihua(resigned on April 17,2021)Independent Non-executive DirectorsDr.Lu ChuanMr.Chen Ju

5、nfaMr.Wang ZhaohuiJoint Company SecretariesMr.Qian Fengqi(appointed on October 27,2021)Ms.Tan Xuan(resigned on October 27,2021)Ms.Chan Sze Ting(ACG,HKACG)Authorized RepresentativesMr.Qian Fengqi(appointed on October 27,2021)Ms.Tan Xuan(resigned on October 27,2021)Ms.Chan Sze TingSupervisorsMr.Zheng

6、Zehui(Chairman)Ms.Tang HaijunMs.Su Jilan(Employee Supervisor)Strategy CommitteeMr.Li Li(Chairman)Ms.Li TanDr.Lu ChuanRemuneration and Evaluation CommitteeMr.Wang Zhaohui(Chairman)Mr.Chen JunfaMr.Li Li董事會執行董事李鋰先生（董事長）李坦女士（副總經理）單宇先生（總經理）張斌先生（於二零二一年五月二十六日獲委任）（於二零二二年四月二十九日辭任）孫暄先生（副董事長）（於二零二一年五月六日辭任）非執行董